Search papers, labs, and topics across Lattice.
The paper introduces Mixed-SuStaIn, a disease progression model built within the Subtype and Stage Inference (SuStaIn) framework, designed to handle both discrete and continuous data types simultaneously. This addresses the limitation of existing models that are typically specific to a single data type, hindering their applicability to heterogeneous real-world datasets. The model's effectiveness is demonstrated through simulations and application to Alzheimer's Disease Neuroimaging Initiative (ADNI) data, showcasing its ability to model disease progression with mixed data.
Unlock richer disease insights by modeling both discrete and continuous biomarkers simultaneously, revealing hidden subtypes and progression stages previously obscured by single-data-type limitations.
Disease progression modeling provides a robust framework to identify long-term disease trajectories from short-term biomarker data. It is a valuable tool to gain a deeper understanding of diseases with a long disease trajectory, such as Alzheimer's disease. A key limitation of most disease progression models is that they are specific to a single data type (e.g., continuous data), thereby limiting their applicability to heterogeneous, real-world datasets. To address this limitation, we propose the Mixed Events model, a novel disease progression model that handles both discrete and continuous data types. This model is implemented within the Subtype and Stage Inference (SuStaIn) framework, resulting in Mixed-SuStaIn, enabling subtype and progression modeling. We demonstrate the effectiveness of Mixed-SuStaIn through simulation experiments and real-world data from the Alzheimer's Disease Neuroimaging Initiative, showing that it performs well on mixed datasets. The code is available at: https://github.com/ucl-pond/pySuStaIn.
